Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology: A Systematic Review and Quantitative Analysis.

Overview of attention for article published in JAMA Internal Medicine, December 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 22 news outlets
blogs: 4 blogs
policy: 1 policy source

twitter: 597 X users
facebook: 5 Facebook pages
googleplus: 1 Google+ user

Citations

dimensions_citation: 105 Dimensions

Readers on

mendeley: 134 Mendeley

Summary News Blogs Policy documents X Facebook Google+ Misc. Dimensions citations

Altmetric can't track some types of mention—for example, radio or TV appearances—and occasionally we'll miss blogs or news mentions. This tab contains data that we've manually added to this record.

Investigators Question the Use of PFS as a Surrogate End Point

https://www.cancertherapyadvisor.com, 01 Oct 2018

October 01, 2018 Investigators challenge the assumption that PFS and HRQoL are linked, and call into question the use of PFS as…